| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |